EPISODE · Aug 21, 2021 · 15 MIN
S2-E42.1 - FGF drugs in Development - A Promising Class of Agents
from Surfing the MASH Tsunami · host HEP Dynamics
Send us Fan MailProfessor Arun Sanyal and Stephen Harrison provide a 40-minute briefing on fibroblast growth factor (FGF) agents and why they are so important to the future of NASH and NAFLD therapy. This conversation focuses on FGF drug development to date.After a simple opening from Roger Green, this conversation includes 4 key elements:1:05 - Roger Green discusses recent history of FGF agents and podcast episodes discussing them2:11 - Stephen Harrison discusses the efruxifermin BALANCED Phase 2a trial in F2/F3 NASH and Cohort C with cirrhosis patients6:59 - Arun Sanyal and Stephen Harrison discuss future prospects for FGF-21 agents10:34 - Arun Sanyal discusses specific receptor targets for different FGF agents and why they matterThis episode has specific discussions of efruxifermin and mentions of pegbelfermin and MK-3655, the former NGM-313.
Embed this episode
What this episode covers
Send us Fan Mail Professor Arun Sanyal and Stephen Harrison provide a 40-minute briefing on fibroblast growth factor (FGF) agents and why they are so important to the future of NASH and NAFLD therapy. This conversation focuses on FGF drug development to date. After a simple opening from Roger Green, this conversation includes 4 key elements: 1:05 - Roger Green discusses recent history of FGF agents and podcast episodes discussing them 2:11 - Stephen Harrison discusses the efruxifermin BALANCE...
NOW PLAYING
S2-E42.1 - FGF drugs in Development - A Promising Class of Agents
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.